Insulin Therapy News

• CGM With Insulin Injections Could Be Cost-Effective in Diabetes Despite higher initial costs, long-term use of continuous glucose monitoring was shown to be cost-effective in patients with type 1 diabetes taking multiple daily insulin injections.
  Medscape Medical News, April 2018
• Physicians Among Diabetes Activists Protesting Insulin Prices Washington event was among several planned rallies decrying the high cost of insulin and calling for systemic health care change.
  Medscape Medical News, April 2018
• Insulin Requirement Increases With Parity in Pregnant Diabetics Insulin requirement increases with parity in pregnant women with type 1 diabetes, researchers from Denmark report.
  Reuters Health Information, April 2018
• ENDO 2018Closed-Loop Insulin System Works in Kids as Young as 7 Years Medtronic's MiniMed 670G hybrid closed-loop insulin delivery system improves glycemic outcomes in children with type 1 diabetes as young as age 7, according to a study funded by the manufacturer.
  Reuters Health Information, March 2018
• Seeing Red: Fiasp Label Is Changing Color to Avoid Mixups The move follows reports of patients with diabetes mixing up the yellow Fiasp and the light-green Tresiba injection pen labels.
  Medscape Medical News, March 2018
• Fibroblast Growth Factor Analog Shows Promise in Non-alcoholic Steatohepatitis An engineered analog of FGF-19, a hormone that regulates bile-acid synthesis and glucose homoeostasis, rapidly curbs liver fat in patients with non-alcoholic steatohepatitis, but has frequent side effects, according to an industry-funded trial.
  Reuters Health Information, March 2018
• Alert FDA Approves New 'Smart' Continuous Glucose Monitor for Diabetes Designed for patients with diabetes who use multiple daily insulin injections, Medtronic's Guardian Connect is the first stand-alone CGM with predictive capability.
  FDA Approvals, March 2018
• Endocrine Society on Reducing Hypoglycemia in Type 2 Diabetes The Endocrine Society says more work is needed to prevent episodes of hypoglycemia in patients with type 2 diabetes.
  Medscape Medical News, March 2018
• CGM Cuts Hypoglycemia in At-Risk Type 1 Diabetes Patients Prior continuous glucose monitoring studies hadn't included patients with hypoglycemia unawareness or severe hypoglycemia who use insulin injections.
  Medscape Medical News, March 2018
• 'Artificial Pancreas' Is Far From Perfect, but Holds Promise MiniMed 670G, a first-generation semi-automated insulin delivery device, is like a 1990s cell phone, says researcher: it needs hands-on adjustments and a 'steep learning curve,' but is ultimately of benefit.
  Medscape Medical News, February 2018
• Insulin Vials and Pens May Not Contain Sufficient Insulin Analysis of NPH and regular insulin vials from two different manufacturers purchased in US pharmacies finds concentrations far lower than regulations stipulate.
  Medscape Medical News, January 2018
• Medicare Part D to Cover Omnipod Insulin Delivery System Its unique design disqualifies Omnipod from coverage as durable medical equipment, the way other insulin pumps are categorized, but now CMS deems it a medical supply 'associated with the injection of insulin.'
  Medscape Medical News, January 2018
• Medicare to Cover FreeStyle Libre Glucose Monitoring System Device is the second continuous glucose monitor to receive 'nonadjunctive' designation, and the first not to require fingerstick calibrations.
  Medscape Medical News, January 2018
• 'Artificial Pancreas' Works During Intense Exercise An 'artificial pancreas' that monitors blood sugar and automatically delivers insulin may make it safer for teens with type 1 diabetes to participate in sports, a U.S. study suggests.
  Reuters Health Information, December 2017
• Possible Oral Alternative to Insulin for Diabetics With Cystic Fibrosis Although injected insulin is the recommended treatment for cystic-fibrosis-related diabetes, oral repaglinide may be a less demanding alternative, according to findings from a small, open-label multinational trial.
  Reuters Health Information, December 2017
• IDFHype or Hope: Will the 3Cs of Diabetes Tech Revolutionize Care? Some believe technology will transform diabetes care in the future, but there is still a long way to go until it enters mainstream clinical practice globally; so far, only a minority of patients use it.
  Medscape Medical News, December 2017
• Smartphone-Linked Insulin Pen System for Diabetes Launched in US An insulin pen injector system that pairs with a smartphone app to calculate and track insulin dosing, the InPen, a so-called "smart" insulin-delivery device, is now available in the US for use in diabetes.
  Medscape Medical News, December 2017
• Guide Assists in Type 1 Diabetes Health Insurance Navigation in US A JDRF online resource helps people with type 1 diabetes in the US understand insurance options and address obstacles.
  Medscape Medical News, December 2017
• Alert First Humalog Copycat (Admelog) Approved by FDA Sanofi-Aventis' Admelog approved for both diabetes types, and for use via injection or insulin pump.
  FDA Approvals, December 2017
• Needle in a Haystack: Type 1 Diabetes Arises Equally in Adulthood Doctors should be aware that type 1 diabetes is just as likely to occur in adults as in younger individuals but that it is swamped by the preponderance of type 2 as people age, newly published data show.
  Medscape Medical News, December 2017